Similarly, in our study, TMAO administration preserved right ventricular function, as indicated by normalized direct RV pressure and RV fractional area change; moreover, TMAO decreased the expression of a marker of heart failure severity, BNP, in right ventricular tissue. This evidence concerns the gene NPPB and heart failure.